Respiratory Distress Syndrome Newborn
📧 Sign up to get email alerts when something new happens for Respiratory Distress Syndrome Newborn.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-12-30Clinical Trial Update: Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF) [Phase 2]
Phase 2 clinical trial of inhaled prostaglandin E1 for hypoxemic respiratory failure in premature infants was terminated; results posted in …
-
CLINICAL_TRIALS trial_result · 2015-08-26Clinical Trial Update: The Use of Heliox Via Nasal CPAP to Prevent Early CPAP Failure in Premature Infants: A Feasibility Study [NA]
A completed feasibility study evaluating whether heliox delivered through nasal CPAP can prevent early CPAP failure in premature infants wit…
-
CLINICAL_TRIALS trial_result · 2015-07-15Clinical Trial Update: Sedation Management in Pediatric Patients With Acute Respiratory Failure (The RESTORE Study) [Phase 3]
This update reports on the RESTORE study, a Phase 3 trial evaluating sedation management in pediatric patients with acute respiratory failur…
-
CLINICAL_TRIALS trial_result · 2015-01-06Clinical Trial Update: Amniotic Fluid Optical Density Determination as a Test for Assessment of Fetal Lung Maturity. [Phase 3]
Phase 3 clinical trial evaluating amniotic fluid optical density as a test for fetal lung maturity has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-16Clinical Trial Update: Randomized Controlled Trial of Surfactant Delivery Via Laryngeal Mask Airway (LMA) Versus Endotracheal Intubation [Phase 4]
A Phase 4 randomized trial compares surfactant delivery via laryngeal mask airway to endotracheal intubation in newborn respiratory distress…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-09-14Clinical Trial Update: Delivery Room Management Trial of Premature Infants at High Risk of Respiratory Distress Syndrome [Phase 3]
Phase 3 clinical trial update for delivery room management in premature infants at high risk of respiratory distress syndrome; results poste…
-
CLINICAL_TRIALS trial_result · 2012-04-06Clinical Trial Update: Observational Study on the Prophylactic Use of Curosurf in Neonatal Respiratory Distress Syndrome (RDS)
Completion of an observational study evaluating the prophylactic use of Curosurf (poractant alfa) in newborn respiratory distress syndrome.
-
CLINICAL_TRIALS trial_result · 2011-06-28Clinical Trial Update: Efficacy Evaluation of Surfactant Administration Via Laryngeal Mask Airway [Phase 4]
Phase 4 clinical trial update evaluating surfactant administration via a laryngeal mask airway in newborns with respiratory distress syndrom…
-
CLINICAL_TRIALS trial_result · 2010-05-13Clinical Trial Update: Intrapulmonary Percussive Ventilation (IPV) Versus Nasal Continuous Positive Airway Pressure Ventilation (nCPAP) in Transient Respiratory Distress of the Newborn [NA]
This completed clinical trial compared intrapulmonary percussive ventilation (IPV) to nasal continuous positive airway pressure (nCPAP) in n…
-
CLINICAL_TRIALS trial_result · 2009-07-10Clinical Trial Update: Synchronized Intermittent Mandatory Ventilation (SIMV) Versus Nasal Intermittent Positive Pressure Ventilation (NIPPV) In Preterm Infants With Respiratory Distress [Phase 4]
A Phase 4 trial comparing synchronized intermittent mandatory ventilation (SIMV) to nasal intermittent positive pressure ventilation (NIPPV)…
-
EMA withdrawal · 2006-06-08EMA Application withdrawn: Surfaxin (sinapultide;Dipalmitoylphosphatidylcholine;palmitoyl-oleoyl phosphatidylglycerol;palmitic acid) — Pharm Research Associates (UK) Limited
EMA withdrew the application for Surfaxin (sinapultide and lipid components) for Respiratory Distress Syndrome in newborns.